Skip to main content
. 2023 Dec 6;12(24):7531. doi: 10.3390/jcm12247531

Table 4.

Summary of the results and types of rejection related to the expression of indoleamine 2,3-dioxygenase (IDO1). Specific quantities and percentages of positive and negative cases concerning a particular factor are presented.

Biopsy Diagnosis IDO1 Expression in Tubules IDO1(+) Positive n = 76 IDO1 Expression in Tubules IDO1(−) Negative n = 45 p
Rejections (all) 25/76 (32.9%) 28/45 (62.2%) 0.0017
AMR * (including pure and mixed AMR) 4 (5.2%) 9 (20%) 0.0085
TCMR ** (including pure and mixed TCMR) 24 (31.6%) 26 (57.8%) 0.0046
AMR (pure) 1 (1.3%) 2 (4.4%) 0.28
TCMR (pure) 21 (27.69%) 19 (42.2%) 0.10

* Antibody-mediated rejection. ** T-cell-mediated rejection.